Athanor Capital, LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Athanor Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$64.07 - $91.75 $411,329 - $589,035	-6,420 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $417,749 - $630,700	6,420 New	6,420 $550,000
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $216,381 - $285,686	-3,665 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $106,321 - $272,052	3,665 New	3,665 $268,000
Q1 2020 May 14, 2020	SELL	$27.51 - $57.29 $184,317 - $383,843	-6,700 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $294,192 - $415,080	-7,200 Reduced 51.8%	6,700 $365,000
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $343,896 - $455,124	9,200 Added 195.74%	13,900 $580,000
Q2 2019 Aug 13, 2019	BUY	$39.79 - $67.01 $187,013 - $314,947	4,700 New	4,700 $206,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.